In conclusion, GSDMD exists as an oncogene in the occurrence and development of renal cell carcinoma and is related to the prognosis of ccRCC, and its expression increases with the increase of stage and grade, which may become a new marker and therapeutic target in the future treatment of renal cell carcinoma. Here, GSDMD is linked to hereditary clear cell renal cell carcinoma.